Literature DB >> 30613008

[Expression of miR-454-3p and its effect on proliferation, invasion and metastasis of colon cancer].

Wenhua Li1,2, Yun Feng1, Zhenzeng Ma1, Lungen Lu1.   

Abstract

OBJECTIVE: To study the expression of miR-454-3p in colon cancer and its effect on colon cancer proliferation, invasion and hepatic metastasis.
METHODS: Specimens of tumor tissues and paired adjacent tissues were collected from 20 patients with colorectal cancer for detecting the expression levels of miR-454-3p using in situ hybridization. Colon cancer cell line SW480 was transfected with a lentiviral vector to induce miR-454-3p over-expression, and the changes in cell proliferation and invasion were observed using cell counting kit-8 (CCK-8), clone formation assay and Transwell experiment. The effect of miR- 454-3p over-expression on hepatic metastasis of colon cancer was assessed in BALB/c mouse models.
RESULTS: The results of in situ hybridization showed a significantly increased expression level of miR-454-3p in colon cancer tissues as compared with normal colon tissues (P < 0.05). In SW480 cells, over-expression of miR-454-3p significantly promoted the cell proliferation and invasion (P < 0.05). In BALB/c mice, SW480 cells over-expressing miR-454-3p showed a significantly higher potential for liver metastases than the control cells (P < 0.05).
CONCLUSIONS: miR-454-3p is overexpressed in the tumor tissues in patients with colorectal cancer and participates in the progression of colorectal cancer by promoting cancer cell proliferation, invasion, and liver metastasis. miR-454-3p may serve as a novel biomarker for colorectal cancer diagnosis and prognostic evaluation.

Entities:  

Keywords:  colon cancer; invasion; metastasis; microRNA

Mesh:

Substances:

Year:  2018        PMID: 30613008      PMCID: PMC6744220          DOI: 10.12122/j.issn.1673-4254.2018.12.04

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  23 in total

1.  A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.

Authors:  Michael J Pishvaian; Rebecca S Slack; Wei Jiang; A Ruth He; Jimmy J Hwang; Amy Hankin; Karen Dorsch-Vogel; Divyesh Kukadiya; Louis M Weiner; John L Marshall; Jonathan R Brody
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

2.  [Expression of miR-146a in colon cancer and its significance].

Authors:  Changqing Zeng; Liangxiang Huang; Yu Zheng; Haixiao Huang; Linhao Chen; Liangjie Chi
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2014-03

3.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

Review 4.  Regorafenib in the treatment of metastatic colorectal cancer.

Authors:  Christelle de la Fouchardière
Journal:  Future Oncol       Date:  2018-03-23       Impact factor: 3.404

5.  Plasma miR-454-3p as a potential prognostic indicator in human glioma.

Authors:  Naiyuan Shao; Lei Wang; Lian Xue; Rong Wang; Qing Lan
Journal:  Neurol Sci       Date:  2014-09-06       Impact factor: 3.307

6.  Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells.

Authors:  Xin Wu; Nan Ding; Wentao Hu; Jinpeng He; Shuai Xu; Hailong Pei; Junrui Hua; Guangming Zhou; Jufang Wang
Journal:  Radiat Oncol       Date:  2014-08-12       Impact factor: 3.481

7.  miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.

Authors:  Y An; Z Zhang; Y Shang; X Jiang; J Dong; P Yu; Y Nie; Q Zhao
Journal:  Cell Death Dis       Date:  2015-05-21       Impact factor: 8.469

8.  Technical Validation of a Reverse-Transcription Quantitative Polymerase Chain Reaction In Vitro Diagnostic Test for the Determination of MiR-31-3p Expression Levels in Formalin-Fixed Paraffin-Embedded Metastatic Colorectal Cancer Tumor Specimens.

Authors:  Lucas Ramon; Catherine David; Karine Fontaine; Elodie Lallet; Charles Marcaillou; Séverine Martin-Lannerée; Virginie Decaulne; Céline Vazart; Anne-Héloise Gélibert; Raouf Ben Abdelali; Jean-Marc Costa; Francis Rousseau; Raphaële Thiébaut; Larry Yost; Yann Gaston-Mathé
Journal:  Biomark Insights       Date:  2018-03-16

9.  Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.

Authors:  Xing Bao; Tingting Ren; Yi Huang; Kunkun Sun; Shidong Wang; Kuisheng Liu; Bingxin Zheng; Wei Guo
Journal:  Cell Death Dis       Date:  2017-02-09       Impact factor: 8.469

10.  Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy.

Authors:  Chinatsu Otomo; Zoltan Metlagel; Giichi Takaesu; Takanori Otomo
Journal:  Nat Struct Mol Biol       Date:  2012-12-02       Impact factor: 15.369

View more
  2 in total

1.  Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC.

Authors:  Qin Yang; Lin Zhu; Mao Ye; Bin Zhang; Peihe Zhan; Hui Li; Wen Zou; Jing Liu
Journal:  Front Genet       Date:  2022-06-20       Impact factor: 4.772

2.  Mechanism underlying long non‑coding RNA ILF3‑AS1‑mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis.

Authors:  Linmei Zhu; Ruixia Chen; Chunlin Jiang; Qingsheng Xie; Wenshuai Zhao; Xiaohong Gao; Haiming Huang
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.